Literature DB >> 2647890

Properly timed injections of cortisol and prolactin produce long-term reductions in obesity, hyperinsulinaemia and insulin resistance in the Syrian hamster (Mesocricetus auratus).

A H Cincotta1, J M Wilson, C J deSouza, A H Meier.   

Abstract

Naturally obese female Syrian hamsters were injected daily with prolactin at 0 or 12 h after cortisol injections for 10 days while held in constant light. Controls were similarly injected with saline. Animals were then held on short daylengths (10 h light:14 h darkness) for 10 weeks. They were allowed free access to food and water from birth to time of death. Ten weeks after treatment, retroperitoneal fat stores, plasma concentrations of insulin and glucose, and hypoglycaemic responsiveness to exogenous insulin were determined. The control groups as well as the 12-h hormone treatment group were obese, hyperinsulinaemic and insulin resistant. However, the 0-h treatment dramatically reduced retroperitoneal fat stores (41-55%), plasma insulin concentration (60-70%) and the insulin to glucose ratio (63-68%) compared with controls. Values for these parameters in the 0-h treatment groups were similar to those of their lean litter-mates. Furthermore, the 0-h group but not the 12-h group was more sensitive than control animals to the hypoglycaemic effects of exogenous insulin at doses 0.2 and 2.0 U/kg body weight. These results demonstrate that timed daily injections of cortisol and prolactin in specific temporal relationships can produce marked reductions in obesity, hyperinsulinaemia and insulin resistance in the Syrian hamster that persist long after the termination of treatment. This study also suggests an important role for the interactions of circadian neuroendocrine systems in the regulation of these metabolic states.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647890     DOI: 10.1677/joe.0.1200385

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  6 in total

1.  Body composition of prolactin-, growth hormone, and thyrotropin-deficient Ames dwarf mice.

Authors:  Mark L Heiman; Frank C Tinsley; Julie A Mattison; Steven Hauck; Andrzej Bartke
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

2.  Timed bromocriptine administration reduces body fat stores in obese subjects and hyperglycemia in type II diabetics.

Authors:  A H Meier; A H Cincotta; W C Lovell
Journal:  Experientia       Date:  1992-03-15

3.  Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats.

Authors:  Michael Ezrokhi; Shuqin Luo; Yelena Trubitsyna; Anthony H Cincotta
Journal:  Diabetol Metab Syndr       Date:  2014-09-25       Impact factor: 3.320

4.  Circadian peak dopaminergic activity response at the biological clock pacemaker (suprachiasmatic nucleus) area mediates the metabolic responsiveness to a high-fat diet.

Authors:  S Luo; Y Zhang; M Ezrokhi; Y Li; T-H Tsai; A H Cincotta
Journal:  J Neuroendocrinol       Date:  2018-01       Impact factor: 3.627

5.  Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome.

Authors:  Haiyan Yang; Jie Lin; He Li; Zhangwei Liu; Xia Chen; Qianqian Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

6.  Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat Diet.

Authors:  Michael Ezrokhi; Yahong Zhang; Shuqin Luo; Anthony H Cincotta
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.